BACKGROUND AND OBJECTIVES: Awareness of CKD is necessary for patient engagement and adherence to medical regimens. Having an accurate tool to assess awareness is important. Use of the National Health and Nutrition Examination Survey (NHANES) CKD awareness question "Have you ever been told by a doctor or other health professional that you had weak or failing kidneys (excluding kidney stones, bladder infections, or incontinence)?" produces surprisingly low measures of CKD awareness. We sought to compare the sensitivity and specificity of different questions ascertaining awareness of CKD and other health conditions. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Between August of 2011 and August of 2014, an in-person questionnaire was administered to 220 adults with CKD, diabetes, hypertension, or hyperlipidemia who received primary care in a public health care delivery system to ascertain awareness of each condition. CKD awareness was measured using the NHANES question, and other questions, asking if patients knew about their "kidney disease", "protein in the urine", "kidney problem", or "kidney damage." Demographic data were self-reported; health literacy was measured. The sensitivity and specificity of each question was calculated using the medical record as the gold standard. RESULTS: In this diverse population (9.6% white, 40.6% black, 36.5% Hispanic, 12.3% Asian), the mean age was 58 years, 30% had a non-English language preference, and 45% had low health literacy. Eighty percent of participants had CKD, with a mean eGFR of 47.2 ml/min per 1.73 m(2). The sensitivities of each CKD awareness question were: 26.4% for "kidney damage", 27.7% for "kidney disease", 33.2% for "weak or failing kidneys", 39.8% for "protein in the urine", and 40.1% for "kidney problem." Specificities ranged from 82.2% to 97.6%. The best two-question combination yielded a sensitivity of 53.1% and a specificity of 83.3%. This was lower than awareness of hypertension (90.1%) or diabetes (91.8%). CONCLUSIONS: CKD awareness is low compared with other chronic diseases regardless of how it is ascertained. Nevertheless, more sensitive questions to ascertain CKD awareness suggest current under-ascertainment.
BACKGROUND AND OBJECTIVES: Awareness of CKD is necessary for patient engagement and adherence to medical regimens. Having an accurate tool to assess awareness is important. Use of the National Health and Nutrition Examination Survey (NHANES) CKD awareness question "Have you ever been told by a doctor or other health professional that you had weak or failing kidneys (excluding kidney stones, bladder infections, or incontinence)?" produces surprisingly low measures of CKD awareness. We sought to compare the sensitivity and specificity of different questions ascertaining awareness of CKD and other health conditions. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Between August of 2011 and August of 2014, an in-person questionnaire was administered to 220 adults with CKD, diabetes, hypertension, or hyperlipidemia who received primary care in a public health care delivery system to ascertain awareness of each condition. CKD awareness was measured using the NHANES question, and other questions, asking if patients knew about their "kidney disease", "protein in the urine", "kidney problem", or "kidney damage." Demographic data were self-reported; health literacy was measured. The sensitivity and specificity of each question was calculated using the medical record as the gold standard. RESULTS: In this diverse population (9.6% white, 40.6% black, 36.5% Hispanic, 12.3% Asian), the mean age was 58 years, 30% had a non-English language preference, and 45% had low health literacy. Eighty percent of participants had CKD, with a mean eGFR of 47.2 ml/min per 1.73 m(2). The sensitivities of each CKD awareness question were: 26.4% for "kidney damage", 27.7% for "kidney disease", 33.2% for "weak or failing kidneys", 39.8% for "protein in the urine", and 40.1% for "kidney problem." Specificities ranged from 82.2% to 97.6%. The best two-question combination yielded a sensitivity of 53.1% and a specificity of 83.3%. This was lower than awareness of hypertension (90.1%) or diabetes (91.8%). CONCLUSIONS: CKD awareness is low compared with other chronic diseases regardless of how it is ascertained. Nevertheless, more sensitive questions to ascertain CKD awareness suggest current under-ascertainment.
Authors: Julie A Wright Nunes; Kenneth A Wallston; Svetlana K Eden; Ayumi K Shintani; T Alp Ikizler; Kerri L Cavanaugh Journal: Kidney Int Date: 2011-08-10 Impact factor: 10.612
Authors: Adam Whaley-Connell; James R Sowers; Peter A McCullough; Tricia Roberts; Samy I McFarlane; Shu-Cheng Chen; Suying Li; Changchun Wang; Allan J Collins; George L Bakris Journal: Am J Kidney Dis Date: 2009-04 Impact factor: 8.860
Authors: Pamela A Lopez-Vargas; Allison Tong; Richard K S Phoon; Steven J Chadban; Yvonne Shen; Jonathan C Craig Journal: Nephrology (Carlton) Date: 2014-04 Impact factor: 2.506
Authors: Lisa D Chew; Joan M Griffin; Melissa R Partin; Siamak Noorbaloochi; Joseph P Grill; Annamay Snyder; Katharine A Bradley; Sean M Nugent; Alisha D Baines; Michelle Vanryn Journal: J Gen Intern Med Date: 2008-03-12 Impact factor: 5.128
Authors: Delphine S Tuot; Laura C Plantinga; Suzanne E Judd; Paul Muntner; Chi-Yuan Hsu; David G Warnock; Orlando M Gutiérrez; Monika Safford; Neil R Powe; William M McClellan Journal: Am J Nephrol Date: 2013-01-31 Impact factor: 3.754
Authors: Mohammad A Tahir; Olga Dmitrieva; Simon de Lusignan; Jeremy van Vlymen; Tom Chan; Ramez Golmohamad; Kevin Harris; Charles Tomson; Nicola Thomas; Hugh Gallagher Journal: BMC Fam Pract Date: 2011-08-05 Impact factor: 2.497
Authors: Lynda A Szczech; Rebecca C Stewart; Hsu-Lin Su; Richard J DeLoskey; Brad C Astor; Chester H Fox; Peter A McCullough; Joseph A Vassalotti Journal: PLoS One Date: 2014-11-26 Impact factor: 3.240
Authors: Eli Farhy; Clarissa Jonas Diamantidis; Rebecca M Doerfler; Wanda J Fink; Min Zhan; Jeffrey C Fink Journal: Clin J Am Soc Nephrol Date: 2019-06-06 Impact factor: 8.237
Authors: Katherine R Tuttle; Radica Z Alicic; Robert A Short; Joshua J Neumiller; Brian J Gates; Kenn B Daratha; Celestina Barbosa-Leiker; Sterling M McPherson; Naomi S Chaytor; Brad P Dieter; Stephen M Setter; Cynthia F Corbett Journal: Clin J Am Soc Nephrol Date: 2018-01-02 Impact factor: 8.237
Authors: Sri Lekha Tummalapalli; Eric Vittinghoff; Deidra C Crews; Mary Cushman; Orlando M Gutiérrez; Suzanne E Judd; Holly J Kramer; Carmen A Peralta; Delphine S Tuot; Michael G Shlipak; Michelle M Estrella Journal: Am J Nephrol Date: 2020-04-29 Impact factor: 3.754
Authors: Jenna M Norton; Kaltun Ali; Claudine T Jurkovitz; Krzysztof Kiryluk; Meyeon Park; Kensaku Kawamoto; Ning Shang; Sankar D Navaneethan; Andrew S Narva; Paul Drawz Journal: Clin J Am Soc Nephrol Date: 2019-08-12 Impact factor: 8.237
Authors: Karly A Murphy; Raquel C Greer; Debra L Roter; Deidra C Crews; Patti L Ephraim; Kathryn A Carson; Lisa A Cooper; Michael C Albert; L Ebony Boulware Journal: J Gen Intern Med Date: 2019-11-12 Impact factor: 5.128
Authors: Marco D Boonstra; Sijmen A Reijneveld; Elisabeth M Foitzik; Ralf Westerhuis; Gerjan Navis; Andrea F de Winter Journal: Nephrol Dial Transplant Date: 2020-12-22 Impact factor: 5.992
Authors: Chi D Chu; Charles E McCulloch; Tanushree Banerjee; Meda E Pavkov; Nilka R Burrows; Brenda W Gillespie; Rajiv Saran; Michael G Shlipak; Neil R Powe; Delphine S Tuot Journal: Am J Kidney Dis Date: 2020-04-15 Impact factor: 8.860
Authors: Jason E Engel; Erika Williams; Maxx L Williams; Gene L Bidwell; Alejandro R Chade Journal: Hypertension Date: 2019-09-23 Impact factor: 10.190